This inventor holds 4 USPTO granted patents and 2 EPO patents. Top assignee: Beta Pharma, Inc.. Active years: 2006-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2016
Title: Guojian Xie: Innovator in Pharmaceutical Chemistry
Introduction
Guojian Xie is a prominent inventor based in Cheshire, CT, known for his significant contributions to pharmaceutical chemistry. With a total of four patents to his name, Xie has made strides in developing innovative compounds that address critical health issues.
Latest Patents
Among his latest patents is the invention related to Icotinib hydrochloride, which includes its synthesis, crystalline forms, pharmaceutical compositions, and therapeutic uses. This invention focuses on 4-[(3-ethynylphenyl)amino]-6,7-benzo-12-crown-quinazoline hydrochloride, highlighting its new crystalline forms and therapeutic applications for diseases mediated by EGFR kinase. Additionally, it provides synthetic methods for preparing this compound and its relevant intermediates. Another notable patent involves indolinone protein kinase inhibitors, which are new indolinone compounds and their pharmaceutically acceptable salts and prodrugs aimed at treating and preventing VEGFR-related cellular disorders, including cancer.
Career Highlights
Guojian Xie is currently associated with Beta Pharma, Inc., where he continues to innovate in the field of pharmaceuticals. His work has been instrumental in advancing therapeutic options for patients suffering from various diseases.
Collaborations
Throughout his career, Xie has collaborated with notable colleagues, including Don Zhang and Charles Davis. These partnerships have foster
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile